{"transactions":[{"id":4620273,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":77965,"kind":"person","name":"Mason Christopher","position":1,"cik":"0001836440","reported_name":"Mason Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-09-17T00:01:47.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant."}],"balance_after":471,"derivative":{"underlying":"Common Stock","underlying_shares":471},"source":{"system":"sec-edgar","filing":"0001836440-26-000002","document":"wk-form4_1789603304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836440/000183644026000002/wk-form4_1789603304.xml","form_type":"4"}},{"id":4620272,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":77965,"kind":"person","name":"Mason Christopher","position":1,"cik":"0001836440","reported_name":"Mason Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-17T00:01:47.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":1187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant."}],"balance_after":1187,"derivative":{"exercise_price":340.03,"expiration_date":"2036-09-13","underlying":"Common Stock","underlying_shares":1187},"source":{"system":"sec-edgar","filing":"0001836440-26-000002","document":"wk-form4_1789603304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836440/000183644026000002/wk-form4_1789603304.xml","form_type":"4"}},{"id":1099293,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":77965,"kind":"person","name":"Mason Christopher","position":1,"cik":"0001836440","reported_name":"Mason Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-30T22:09:25.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2025 and vest in equal monthly tranches over a one-year period."}],"balance_after":5000,"derivative":{"exercise_price":137.46,"expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001836440-25-000003","document":"wk-form4_1751321359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000183644025000003/wk-form4_1751321359.xml","form_type":"4"}},{"id":1465830,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":77965,"kind":"person","name":"Mason Christopher","position":1,"cik":"0001836440","reported_name":"Mason Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T23:32:09.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2024 and vest in equal monthly tranches over a one-year period."}],"balance_after":5000,"derivative":{"exercise_price":183.64,"expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001836440-24-000004","document":"wk-form4_1719876723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000183644024000004/wk-form4_1719876723.xml","form_type":"4"}},{"id":1839754,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":77965,"kind":"person","name":"Mason Christopher","position":1,"cik":"0001836440","reported_name":"Mason Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T20:24:36.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":6800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2023 and vest in equal monthly tranches over a one-year period."}],"balance_after":6800,"derivative":{"exercise_price":117.4,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":6800},"source":{"system":"sec-edgar","filing":"0001711279-23-000053","document":"wk-form4_1688415856.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000171127923000053/wk-form4_1688415856.xml","form_type":"4"}},{"id":2217362,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":77965,"kind":"person","name":"Mason Christopher","position":1,"cik":"0001836440","reported_name":"Mason Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-01T20:09:23.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":6800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2022 and vest in equal monthly tranches over a one-year period."}],"balance_after":6800,"derivative":{"exercise_price":65.66,"expiration_date":"2032-06-30","underlying":"Common Stock","underlying_shares":6800},"source":{"system":"sec-edgar","filing":"0001711279-22-000036","document":"wf-form4_165670614389935.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000171127922000036/wf-form4_165670614389935.xml","form_type":"4"}},{"id":2644950,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":77965,"kind":"person","name":"Mason Christopher","position":1,"cik":"0001836440","reported_name":"Mason Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T15:30:32.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":6800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2021 and vest in equal monthly tranches over a one-year period."}],"balance_after":6800,"derivative":{"exercise_price":68,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":6800},"source":{"system":"sec-edgar","filing":"0001711279-21-000016","document":"wf-form4_162523981348902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000171127921000016/wf-form4_162523981348902.xml","form_type":"4"}},{"id":2669616,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":77965,"kind":"person","name":"Mason Christopher","position":1,"cik":"0001836440","reported_name":"Mason Christopher","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T22:03:04.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the shares shall vest and become exercisable on June 10, 2023, and the remaining 50% shall vest and become exercisable on June 10, 2024."}],"balance_after":125000,"derivative":{"exercise_price":9.63,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001127602-21-019838","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681087/000112760221019838/form4.xml","form_type":"4"}},{"id":2920999,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":77965,"kind":"person","name":"Mason Christopher","position":1,"cik":"0001836440","reported_name":"Mason Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T22:07:38.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":13600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on January 4, 2021 and vest in equal amounts over 36 months."}],"balance_after":13600,"derivative":{"exercise_price":59.42,"exercise_date":"2024-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":13600},"source":{"system":"sec-edgar","filing":"0000899243-21-000410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000089924321000410/doc4.xml","form_type":"4"}}]}